NKGen Biotech Inc (NASDAQ:NKGN)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 0.42. At the close of trading, the stock’s price was $0.53, to imply a decrease of -0.32% or -$0.01 in intraday trading. The NKGN share’s 52-week high remains $4.06, putting it -666.04% down since that peak but still an impressive 62.26% since price per share fell to its 52-week low of $0.20.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

After registering a -0.32% downside in the last session, NKGen Biotech Inc (NKGN) has traded red over the past five days. The 5-day price performance for the stock is -6.32%, and 9.77% over 30 days. With these gigs, the year-to-date price performance is -18.57%.

NKGN Dividends

NKGen Biotech Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the NKGen Biotech Inc (NKGN) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 174.0 shares. This is just over 0.39% of the total shares, with a market valuation of $92829.0. Data from the same date shows that the other fund manager holds a little less at 66.71, or 0.15% of the shares, all valued at about 35591.0.